Journal articleAnticancer Res2014
Congestive heart failure secondary to gemcitabine nab-paclitaxel in patients with pancreatic cancer.
- Journal
- Anticancer Res
- Published
- 1 December 2014
- Citations
- 6
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Background Gemcitabine plus nab-paclitaxel is a novel combination chemotherapy that is currently being used in patients with metastatic pancreatic cancer. Phase III trials have shown improved survival, response rates, and disease-free progression. … Excerpt only: this text is the publisher’s. Read it in full at the source.